PDF(Pubmed)
Abstract：
UNASSIGNED: Head and neck cancer is common in several parts of the world. It is sixth most prevalent neoplasms in the world. Approximately 900 000 cases diagnosed worldwide per year. It has good prognosis when timely diagnosed and treated appropriately.
UNASSIGNED: This was a retrospective study carried out in the Department of ENT-HNS of Shree Birendra Hospital, Chhauni, Kathmandu from May 2022 to April 2023. All histopathologically proven malignant cases of head and neck region were included in the study. Data were entered in Microsoft excel and managed in SPSS version 22. Analysis was done in the form of percentage and proportion and represented as table where necessary. The study has been registerd in clinical trials and has been reported in line with the STROCSS criteria.
UNASSIGNED: Total 76 patients were analyzed. Age ranged from 17 to 84 years and the most common age group presenting with head and neck cancer was 61-80 years. The most common malignancy was laryngeal cancer (34%) followed by thyroid malignancies (29%). Squamous cell carcinoma was the commonest histological type (48%). Surgery with postoperative radiotherapy (RT)/radioactive iodine (RAI) was found to be the commonest treatment modality.
UNASSIGNED: Head and neck cancers are not uncommon and majority of patients present late with advanced stage cancer. Hence, public awareness, early diagnosis with cost-effective treatment and regular follow-up are needed to improve outcomes of these patients in our society.
UNASSIGNED: This was a retrospective study carried out in the Department of ENT-HNS of Shree Birendra Hospital, Chhauni, Kathmandu from May 2022 to April 2023. All histopathologically proven malignant cases of head and neck region were included in the study. Data were entered in Microsoft excel and managed in SPSS version 22. Analysis was done in the form of percentage and proportion and represented as table where necessary. The study has been registerd in clinical trials and has been reported in line with the STROCSS criteria.
UNASSIGNED: Total 76 patients were analyzed. Age ranged from 17 to 84 years and the most common age group presenting with head and neck cancer was 61-80 years. The most common malignancy was laryngeal cancer (34%) followed by thyroid malignancies (29%). Squamous cell carcinoma was the commonest histological type (48%). Surgery with postoperative radiotherapy (RT)/radioactive iodine (RAI) was found to be the commonest treatment modality.
UNASSIGNED: Head and neck cancers are not uncommon and majority of patients present late with advanced stage cancer. Hence, public awareness, early diagnosis with cost-effective treatment and regular follow-up are needed to improve outcomes of these patients in our society.
摘要：
■头颈癌在世界上几个地区很常见。它是世界上第六大流行的肿瘤。全世界每年约有900.000例确诊病例。及时诊断和适当治疗，预后良好。
■这是一项在ShreeBirendra医院的ENT-HNS部门进行的回顾性研究，Chhauni,加德满都从2022年5月到2023年4月。所有经组织病理学证实的头颈部恶性病例均纳入研究。数据在MicrosoftExcel中输入，并在SPSS版本22中进行管理。以百分比和比例的形式进行分析，并在必要时用表格表示。该研究已在临床试验中注册，并已报告符合STROCSS标准。
■共76例患者进行了分析。年龄范围为17至84岁，最常见的头颈部癌症患者为61-80岁。最常见的恶性肿瘤是喉癌（34%），其次是甲状腺恶性肿瘤（29%）。鳞状细胞癌是最常见的组织学类型（48％）。术后放疗（RT）/放射性碘（RAI）手术被发现是最常见的治疗方式。
头颈部癌症并不少见，大多数患者晚期癌症。因此，公众意识,在我们的社会中,需要通过具有成本效益的治疗和定期随访进行早期诊断,以改善这些患者的预后.
■这是一项在ShreeBirendra医院的ENT-HNS部门进行的回顾性研究，Chhauni,加德满都从2022年5月到2023年4月。所有经组织病理学证实的头颈部恶性病例均纳入研究。数据在MicrosoftExcel中输入，并在SPSS版本22中进行管理。以百分比和比例的形式进行分析，并在必要时用表格表示。该研究已在临床试验中注册，并已报告符合STROCSS标准。
■共76例患者进行了分析。年龄范围为17至84岁，最常见的头颈部癌症患者为61-80岁。最常见的恶性肿瘤是喉癌（34%），其次是甲状腺恶性肿瘤（29%）。鳞状细胞癌是最常见的组织学类型（48％）。术后放疗（RT）/放射性碘（RAI）手术被发现是最常见的治疗方式。
头颈部癌症并不少见，大多数患者晚期癌症。因此，公众意识,在我们的社会中,需要通过具有成本效益的治疗和定期随访进行早期诊断,以改善这些患者的预后.
